<h1 itemprop="aspect"> <strong>Marqibo Side Effects</strong></h1><div class="thumbnail-div"> <img width="84" height="84" src="http://www.bad-drug.net/wp-content/uploads/2012/08/marqibo-84x84.jpg?1df917" class="attachment-84x84 wp-post-image" alt="Marqibo" title="Marqibo" pagespeed_url_hash="4016106061" onload="pagespeed.CriticalImages.checkImageForCriticality(this);"/></div><h1>Serious side effects</h1><ul><li>Cardiac arrest, including respiratory distress and failure, and intracerebral and pulmonary hemorrhage</li><li>Hypotension and low white blood cell counts (febrile neutropenia) and low blood pressure, including low platelets in the blood (thrombocytopenia), which all can cause low immunity and <strong>infections</strong></li><li>Nerve damage like peripheral and cranial neurophathy, which can include <strong>sensory/motor problems</strong> and pains</li><li>Tumor lysis syndrome (metabolic complications after cancer treatment), and liver failure due to septic shock</li></ul><h2>Common side effects</h2><ul><li><strong>Digestive problems</strong> such as constipation, nausea, diarrhea and decreased appetite may occur</li><li>Anemia can result in insomnia, fatigue/weakness, fever and pneumonia.</li></ul><div><div title="Page 1"><h2></h2></div></div></div><div class="v" id="tab2" ><h2 itemprop="aspect"> <strong> Warnings & Recalls for Marqibo </strong></h2><h1>Marqibo Black Box Warning</h1> Marqibo can only be administered through a vein (intravenously). It is deadly if administered through any other method, particularly if administered intrathecally (directly into the spinal fluid). Marqibo has a different dosage than vinCRIStine sulfate injections. This drug requires a medical professional to monitor the patient's motor and sensory reactions. Extravasation (the leakage of the medicine to the surrounding tissue) can cause tissue injury.<div title="Page 1"><h2>General Warnings &amp; Contraindications</h2> Marqibo may cause fetal harm in pregnant women, and should not be used by those who are pregnant or trying to become pregnant..Contraindications:<ul><li>In patients with Charcot-Marie-Tooth syndrome</li><li>In patients with hypersensitivity to vinCRIStine sulfate</li><li>Intrathecal administration (directly into spinal fluid)</li></ul><div title="Page 1"><div title="Page 1">&nbsp;</div></div></div></div><div class="v" id="tab3" ><h2 itemprop="aspect"> <strong> Marqibo Treatment and Use </strong></h2><div class="thumbnail-div"> <img width="84" height="84" src="http://www.bad-drug.net/wp-content/uploads/2012/08/marqibo-84x84.jpg?1df917" class="attachment-84x84 wp-post-image" alt="Marqibo" title="Marqibo" pagespeed_url_hash="4016106061" onload="pagespeed.CriticalImages.checkImageForCriticality(this);"/></div><p><strong>Marqibo</strong> | vinCRIStine sulfate liposome is an injection used to treat adults with <strong>Philadelphia chromosome-negative acute lymphoblastic leukemia</strong> after a relapse, or if the disease has continued after leukemia treatment. It is produced by Talon Therapeutics Inc.</p><h2>How does Marqibo work?</h2><p>Marqibo is made of vincristine sulfate (a vinca alkoloid inhibitor used in anti-cancer chemotherapy that divides cancer cells) and a liposome which contains the Optisome encapsulation technology that circulates vincristine in the blood for longer than without the technology. Vincristine is by itself FDA-approved for Non-Hodgkin&#8217;s Lymphoma and also used for hematologic and tumor malignancies.</p><h2>Dosage</h2><p>Marqibo&#8217;s recommended dose is 2.25 mg/m<sup>2</sup> injected intravenously by a health care professional over one hour every seven days.</p><p>&nbsp;</p></div><div class="v" id="tab4" ><h2 itemprop="aspect"> Other Names for Marqibo</h2> <strong>Brand Name:</strong><br/><ul><br/><li>Marqibo</li><br/></ul><br/> <strong>Generic Name:</strong><br/><ul><br/><li>vinCRIStine sulfate liposome injection</li><br/></ul></div><div class="v" id="tab5" ><h2 itemprop="aspect"> <strong> Lawsuits & Legal Information for Marqibo </strong></h2>